The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice
Open accessAbstract
Diffuse large B cell lymphomas (DLBCL) derive from germinal center (GC) B cells and display chromosomal alterations deregulating the expression of BCL6, a transcriptional repressor required for GC formation. To investigate the role of BCL6 in DLBCL pathogenesis, we have engineered mice that express BCL6 constitutively in B cells by mimicking a chromosomal translocation found in human DLBCL. These mice display increased GC formation and perturbed post-GC differentiation characterized by a decreased number of post-isotype switch plasma cells. Subsequently, these mice develop a lymphoproliferative syndrome that culminates with the development of lymphomas displaying features typical of human DLBCL. These results define the oncogenic role of BCL6 in the pathogenesis of DLBCL and provide a faithful mouse model of this common disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In genetically engineered mice, overexpression of BCL6 is sufficient to drive lymphoma development17.”
From Small-molecule-induced polymerization triggers degradation of BCL6 (2020) · cites this paper as [17]
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,524
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,475
Cancer: Principles and Practice of Oncology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,913
Clonal selection and learning in the antibody system
Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,701
Shaffer, A. L., Lin, K., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,048
Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6
Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., & Staudt, L. M. (1997) · Science · doi:10.1126/science.276.5312.589 · Cited by 950
Shaffer, A. L., Yu, X., He, Y., Boldrick, J. C., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 879
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q. “., Zhang, J., Hawe, N., de Waard, R., Leung, C. C., Nouri-Shirazi, M. A., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Self-citationCellular Origin of Human B-Cell Lymphomas
Küppers, R., Klein, U., Hansmann, M., & Rajewsky, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412007 · Cited by 715
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
Phan, R. T., & Dalla‐Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 705
Self-citation
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 387
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL
Li, L., Zhang, X., Zhang, T., Song, Z., Hu, G., Li, W., Li, L., Qiu, L., Qian, Z., Zhou, S., et al. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.06.010 · Cited by 23
C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
Salam, D.-S. D. A., Thit, E. E., Teoh, S. H., Tan, S., Peh, S. C., & Cheah, S. (2019) · Journal of Cancer · doi:10.7150/jca.36954 · Cited by 22
Lodhi, N., Tun, M., Nagpal, P., Inamdar, A. A., Ayoub, N. M., Siyam, N., Oton, L., Gerona, A., Morris, D., Sandhu, R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27785 · Cited by 22
Takata, K., Chong, L. C., Ennishi, D., Aoki, T., Li, M. Y., Thakur, A., Healy, S., Viganò, E., Dao, T., Kwon, D., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci145343 · Cited by 24
Evans, S. E., Goult, B. T., Fairall, L., Jamieson, A. G., Ferrigno, P. K., Ford, R., Schwabe, J. W. R., & Wagner, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090889 · Cited by 21
Yamamoto, K., Lee, B. J., Li, C., Dubois, R. L., Hobeika, E., Bhagat, G., & Zha, S. (2015) · Leukemia · doi:10.1038/leu.2015.41 · Cited by 20
Santis, F. D., Romero-Cordoba, S. L., Castagnoli, L., Volpari, T., Faraci, S., Fucà, G., Tagliabue, E., de Braud, F., Pupa, S. M., & Nicola, M. D. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00663-y · Cited by 21
Njeru, S. N., Kraus, J. M., Meena, J. K., Lechel, A., Katz, S., Kumar, M., Knippschild, U., Azoitei, A., Wezel, F., Bolenz, C., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1073-2 · Cited by 20
Schenten, D., Egert, A., Pasparakis, M., & Rajewsky, K. (2006) · Blood · doi:10.1182/blood-2005-10-4154 · Cited by 21
Biology of Germinal Center B Cells Relating to Lymphomagenesis
Basso, K. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000582 · Cited by 22
Pero, R., Palmieri, D., Angrisano, T., Valentino, T., Federico, A., Franco, R., Lembo, F., Klein–Szanto, A. J., Vecchio, L. D., Montanaro, D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.346270 · Cited by 20
RetractedBatlle‐López, A., Cortiguera, M. G., Rosa‐Garrido, M., Blanco, R. E., del Cerro, E., Torrano, V., Wagner, S. D., & Delgado, M. D. (2013) · Oncogene · doi:10.1038/onc.2013.535 · Cited by 19
Coles, A. H., Marfella, C. G. A., Imbalzano, A. N., Steinman, H. A., Garlick, D. S., Gerstein, R. M., & Jones, S. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0923 · Cited by 22
Sevilla, D. W., Murty, V. V. V. S., Sun, X., Nandula, S. V., MANSUKHANI, M. M., Alobeid, B., & Bhagat, G. (2010) · Hematological Oncology · doi:10.1002/hon.958 · Cited by 19
Self-citationMacor, P., Secco, E., Zorzet, S., Tripodo, C., Celeghini, C., & Tedesco, F. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785294591 · Cited by 19
Lou, Z., Casali, P., & Xu, Z. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00537 · Cited by 21
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme
Ruggieri, S., Tamma, R., Marzullo, A., Annese, T., Marinaccio, C., Errede, M., Susca, F. C., Senetta, R., Cassoni, P., Vacca, A., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.017 · Cited by 19
Regulation of B cell differentiation by the ubiquitin-binding protein TAX1BP1
Matsushita, N., Suzuki, M., Ikebe, E., Nagashima, S., Inatome, R., Asano, K., Tanaka, M., Matsushita, M., Kondo, E., Iha, H., et al. (2016) · Scientific Reports · doi:10.1038/srep31266 · Cited by 18
Lossos, I. S. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.012 · Cited by 18
Burack, R., Spence, J. M., Spence, J. P., Spence, S. A., Rock, P. J., Shenoy, G. N., Shultz, L. D., Bankert, R. B., & Bernstein, S. H. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017005892 · Cited by 17
Kusam, S., & Dent, A. L. (2007) · Immunologic Research · doi:10.1007/bf02697368 · Cited by 17
Batlle, A., Papadopoulou, V., Gomes, A., Willimott, S., Melo, J. V., Naresh, K. N., Lam, E. W. ‐., & Wagner, S. D. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.003 · Cited by 17
Lewis, T. S., McCormick, R. S., Stone, I. J., Emmerton, K. K., Mbow, B., Miyamoto, J., Drachman, J. G., Grewal, I. S., & Law, C.-L. (2011) · Leukemia · doi:10.1038/leu.2011.21 · Cited by 16
Buchberger, E., Payrhuber, D., Harchi, M. E., Zagrapan, B., Scheuba, K. M., Zommer, A., Bugyik, E., Döme, B., Kral-Pointner, J. B., Schrottmaier, W. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13477 · Cited by 16
The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma
Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-07806-8 · Cited by 16
Metastasis-Associated Protein 1 Transgenic Mice: A New Model of Spontaneous B-Cell Lymphomas
Bagheri‐Yarmand, R., Balasenthil, S., Gururaj, A. E., Talukder, A. H., Wang, Y., Lee, J. H., Kim, Y. S., Zhang, X., Jones, D. M., Medeiros, L. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0748 · Cited by 15
An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach
Yanguas‐Casás, N., Pedrosa, L., Fernández‐Miranda, I., & Sánchez‐Beato, M. (2021) · Cancers · doi:10.3390/cancers13122893 · Cited by 20
Kellner, J. N., Wallace, C. H., Liu, B., & Li, Z. (2019) · JCI Insight · doi:10.1172/jci.insight.124698 · Cited by 15
Msh6 Protects Mature B Cells from Lymphoma by Preserving Genomic Stability
Peled, J. U., Sellers, R. S., Iglesias-Ussel, M. D., Shin, D.-M., Montagna, C., Zhao, C., Li, Z., Edelmann, W., Morse, H. C., & Scharff, M. D. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100234 · Cited by 14
Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor
Mamai, A., Chau, A. M., Wilson, B. J., Watson, I. D. G., Joseph, B. B., Subramanian, P. R., Morshed, M. M., Morin, J. A., Prakesch, M. A., Lu, T., et al. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00502 · Cited by 14
Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones
Harnden, A. C., Davis, O. A., Box, G., Hayes, A., Johnson, L. D., Henley, A. T., Brandon, A. K. D. H., Valenti, M. R., Cheung, K.-M. J., Brennan, A., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00155 · Cited by 13
Mouse Models of Germinal Center Derived B-Cell Lymphomas
Meyer, S. N., Koul, S., & Pasqualucci, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710711 · Cited by 18
Self-citationRivas, M. A., Durmaz, C., Kloetgen, A., Chin, C. R., Chen, Z., Bhinder, B., Koren, A., Viny, A. D., Scharer, C. D., Boss, J. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688493 · Cited by 12
Cai, Y., Poli, A. N. R., Vadrevu, S. K., Gyampoh, K., Hart, C., Ross, B. N., Fair, M., Xue, F., Salvino, J. M., & Montaner, L. J. (2021) · European Journal of Immunology · doi:10.1002/eji.202049150 · Cited by 12
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760
Shunatona, H. P., Holmberg‐Douglas, N., Rhodes, J., Thomas, W., Silva, D. D., Gamez, J., Groza, M., Christoforou, A., Zhu, J., Johnson, S. A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01645 · Cited by 12
Liu, J., & Zhang, H. (2024) · Biomolecules · doi:10.3390/biom14020192 · Cited by 12
Diehl, C., Soberón, V., Baygün, S., Chu, Y., Mandelbaum, J., Kraus, L., Engleitner, T., Rudelius, M., Fangazio, M., Daniel, C., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.023 · Cited by 12
Self-citationMYCN Amplifications and Metabolic Rewiring in Neuroblastoma
Pouliou, M., Koutsi, M. A., Champezou, L., Giannopoulou, A.-I., Vatsellas, G., Piperi, C., & Agelopoulos, M. (2023) · Cancers · doi:10.3390/cancers15194803 · Cited by 12
Prognostic Impact of the MDM2SNP309 Allele in Leukemia and Lymphoma
Post, S. M., Pant, V., Abbas, H. A., & Quintás‐Cardama, A. (2010) · Oncotarget · doi:10.18632/oncotarget.123 · Cited by 11
Follicular lymphoma: State‐of‐the‐art ICML workshop in Lugano 2015
Gascoyne, R. D., Nadel, B., Pasqualucci, L., Fitzgibbon, J., Payton, J. E., Melnick, A. M., Weigert, O., Tarte, K., Gribben, J. G., Friedberg, J. W., et al. (2017) · Hematological Oncology · doi:10.1002/hon.2411 · Cited by 11
Self-citationNew genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL)
Reis, D., Levy, D., Lage, L. A. D. P. C., Culler, H. F., Rocha, V., Bydlowski, S. P., Zerbini, M. C. N., & Pereira, J. (2021) · Brain and Behavior · doi:10.1002/brb3.2061 · Cited by 11
BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells
Kusam, S., Munugalavadla, V., Sawant, D. V., & Dent, A. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24450 · Cited by 11
He, M., Liu, B., Tang, G., Jiao, L., Liu, X., Yin, S., Wang, T., Chen, J., Gao, L., Ni, X., et al. (2022) · Journal of Cancer · doi:10.7150/jca.75813 · Cited by 10
Targeting aggressive B-cell lymphomas with cell-penetrating peptides
Melnick, A. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350802 · Cited by 10
Gifford, G. K., Gill, A. J., & Stevenson, W. S. (2015) · Pathology · doi:10.1016/j.pathol.2015.11.017 · Cited by 11
Sakaguchi, N., & Maeda, K. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.02.003 · Cited by 9
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
Giorgio, E. D., Benetti, R., Kerschbamer, E., Xodo, L. E., & Brancolini, C. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.03.013 · Cited by 9
Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma
Lin, A. Y., & Gordon, L. I. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171310 · Cited by 8
Huang, D., Chan, M., Solomon, M. O., Cedars, M. I., Giudice, L. C., & Çakmak, H. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.04.021 · Cited by 8
A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia
Zhang, L., Wu, M., Guo, W., Zhu, S., Li, S., Lv, S., Li, Y., Liu, L., Xing, Y., Huang, C., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115358 · Cited by 8
Granadino‐Roldán, J. M., Obiol‐Pardo, C., Pinto, M., Garzón‐Ruiz, A., & Rubio, J. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2014.04.003 · Cited by 8
Bcl6 Is Expressed in Neuroblastoma: Tumor Cell Type-Specific Expression Predicts Outcome
Chamdin, A., Jarzembowski, J. A., Subramanian, C., Kuick, R. D., Lee, J. J., Kwok, R. P. S., Castle, V. P., & Opipari, A. W. (2009) · Translational Oncology · doi:10.1593/tlo.08220 · Cited by 8
Piskorowska, J., Gajewska, M. E., Szymańska, H., Krysiak, E., Quan, L., Grygalewicz, B., Skurzak, H., Czarnomska, A., Pieńkowska‐Grela, B., & Démant, P. (2011) · Journal of Radiation Research · doi:10.1269/jrr.10035 · Cited by 8
Briones, J. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.11 · Cited by 8
Backbone resonance assignment of the BCL6-BTB/POZ domain
Lin, L., Evans, S. E., Fairall, L., Schwabe, J. W. R., Wagner, S. D., & Muskett, F. W. (2017) · Biomolecular NMR Assignments · doi:10.1007/s12104-017-9778-z · Cited by 8
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
Hoppe, M. M., Jaynes, P. W., Shuangyi, F., Peng, Y., Sridhar, S., Hoang, P. M., Liu, C. X., Mel, S. D., Poon, L. M., Chan, E. H. L., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0998 · Cited by 7
Ye, D., Zhou, S. Y., Dai, X., Xu, H., Tang, Q., Huang, H., & Bi, F. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189161 · Cited by 8
Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
Janakiram, M., Thirukonda, V. K., Sullivan, M., & Petrich, A. M. (2012) · Current Treatment Options in Oncology · doi:10.1007/s11864-011-0178-9 · Cited by 7
Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma
Wagner, S. D., Amen, F., Trivedi, P. S., Horncastle, D. E., Elderfield, K., & Naresh, K. N. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701458491 · Cited by 7
Luo, H., Schmidt, J. A., Lee, Y.-S., Oltz, E. M., & Payton, J. E. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1190973 · Cited by 7
Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice
Raboso-Gallego, J., Casado-García, A., Jiang, X., Isidro-Hernández, M., Gentles, A. J., Zhao, S., Natkunam, Y., Blanco, Ó., Domínguez, V., Pintado, B., et al. (2020) · Blood · doi:10.1182/blood.2020004996 · Cited by 7
Novel treatment strategies for aggressive non-Hodgkin’s lymphoma
Fayad, L., & Younes, A. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.733 · Cited by 7
Mouse Models in the Study of Mature B-Cell MalignanciesPreprint
Pasqualucci, L., & Klein, U. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034827 · Cited by 8
Self-citationLee, S.-M., Lee, J.-Y., Yoo, D.-G., Jeon, Y.-B., Yoon, H. S., & Kim, C. (2022) · Journal of Dairy Science and Biotechnology · doi:10.22424/jdsb.2022.40.1.23 · Cited by 7
Balikó, A., Szakács, Z., Kajtár, B., Ritter, Z., Gyenesei, A., Farkas, N., Kereskai, L., Valyi-Nagy, I. T., Alizadeh, H., & Pajor, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1224733 · Cited by 6
Unraveling the role of cancer-associated fibroblasts in B cell lymphoma
Mukherjee, P., Ansell, S. M., & Mondello, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1451791 · Cited by 6
Jouybar, M., Mikula, A. M., Zuidmeer, N., Konijn, T., de Jonge, A. V., Roest, H. P., Mutis, T., van der Laan, L. J. W., Mebius, R. E., den Toonder, J. M. J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101544 · Cited by 7
Dharanipragada, P., & Parekh, N. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz024 · Cited by 6
Khan, M. Z. I., Nazli, A., Pan, Y., & Chen, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220803112409 · Cited by 7
Bosch, R., Moreno, M. J., Dieguez‐Gonzalez, R., Céspedes, M. V., Gallardo, A., Nomdedeu, J. F., Pavón, M. Á., Espinosa, Í., Mangues, M. A., Sierra, J., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9454-8 · Cited by 6
Bcl6: Where too much complexity is barely enough
Tarlinton, D. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201141891 · Cited by 6
Mouse Models of Human Blood Cancers
Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9 · Cited by 6
Knockout Mouse Models Provide Insight into the Biological Functions of CRL1 Components
Nakagawa, T., Nakayama, K., & Nakayama, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_10 · Cited by 6
Mouse Models of Human Mature B-Cell and Plasma Cell Neoplasms
Janz, S., Morse, H. C., & Teitell, M. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9_8 · Cited by 6
B-Cell Differentiation: Instructive One Day, Stochastic the Next
Tarlinton, D. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.02.045 · Cited by 6
Mouse models of cancer as biological filters for complex genomic data
Oricchio, E., Wolfe, A. L., Schatz, J. H., Mavrakis, K. J., & Wendel, H. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006296 · Cited by 7
Hit-and-run lymphomagenesis by theBcl6oncogene
Green, M. R., Vicente‐Dueñas, C., Alizadeh, A. A., & Sánchez-Garcı́a, I. (2014) · Cell Cycle · doi:10.4161/cc.29326 · Cited by 6
Xing, Y., Tan, C., Liu, Z., Liu, Y., Liu, S., Wang, G., & Zhong, Y. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-024-01873-4 · Cited by 5
Mouse models of diffuse large B cell lymphoma
Tabatabai, A., Arora, A., Höfmann, S., Jauch, M., von Tresckow, B., Hansen, J., Flümann, R., Jachimowicz, R. D., Klein, S., Reinhardt, H. C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1313371 · Cited by 6
Takahara, T., Matsuo, K., Seto, M., Nakamura, S., & Tsuzuki, S. (2016) · Cancer Science · doi:10.1111/cas.13057 · Cited by 5
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System
Hong, Y., Singh, N., Bamopoulos, S. A., Gjerga, E., Schmalbrock, L. K., Balabanian, K., Schick, M., Keller, U. B., & Wirth, M. (2020) · Biomedicines · doi:10.3390/biomedicines8120590 · Cited by 5
B cell lymphoma 6A regulates immune development and function in zebrafish
Almohaisen, F. L. J., Heidary, S., Sobah, M. L., Ward, A. C., & Liongue, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.887278 · Cited by 5
Generation and characterization of the Eµ-Irf8 mouse model
Qiu, Z., Holder, K. N., Lin, A.-P., Myers, J., Jiang, S., Gorena, K. M., Kinney, M. C., & Aguiar, R. C. T. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.05.002 · Cited by 5
Wu, X., & Jelinek, D. F. (2005) · Nature Immunology · doi:10.1038/ni1005-964 · Cited by 5
The Tumor Suppressive Role of PATZ1 in Thyroid Cancer: A Matter of Epithelial-Mesenchymal Transition
Fedele, M., & Cerchia, L. (2016) · Chemotherapy Open access · doi:10.4172/2167-7700.1000198 · Cited by 5
Prospects of Modulating Protein–Protein Interactions
Zhong, S., Oashi, T., Yu, W., Shapiro, P., & MacKerell, A. D. (2012) · Wiley eBooks · doi:10.1002/9783527645947.ch15 · Cited by 5
Horiguchi, H., Xu, H., Duvert, B., Ciuculescu, F., Yao, Q., Sinha, A., McGuinness, M. K., Harris, C. E., Brendel, C., Troeger, A., et al. (2022) · Small GTPases · doi:10.1080/21541248.2021.2019503 · Cited by 3
Ding, Z., Quast, I., Yan, F., Liao, Y., Pitt, C., O’Donnell, K., Robinson, M. J., Shi, W., Kallies, A., Zotos, D., et al. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12578 · Cited by 5
Functional genomics lead to new therapies in follicular lymphoma
Oricchio, E., & Wendel, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12120 · Cited by 4
T cell immunosurveillance controls B lymphoma development
Kallies, A. (2014) · OncoImmunology · doi:10.4161/onci.28697 · Cited by 4
New murine models of aggressive lymphoma
Flümann, R., Nieper, P., Reinhardt, H. C., & Knittel, G. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1691200 · Cited by 6
Malaney, P., Velasco‐Estevez, M., Aguilar-Garrido, P., Aitken, M. J. L., Chan, L. E., Zhang, X., Post, S. M., & Gallardo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634584 · Cited by 5
Barbier, M. T., & Valle, L. D. (2023) · Viruses · doi:10.3390/v15030755 · Cited by 4
Tian, F., Li, J., Li, Y., & Luo, S. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.19 · Cited by 4
Novel Epigenetic Targets in Lymphoproliferative Disorders
Delgado, J. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133222 · Cited by 4
Chromosomal Translocations in B Cell Lymphomas
Fangazio, M., Pasqualucci, L., & Dalla‐Favera, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_9 · Cited by 4
Self-citationActivation-induced deaminase expression defines mature B cell lymphoma in the mouse
Gómez‐Escolar, C., Marina-Zárate, E., & Ramiro, A. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1268930 · Cited by 3
Analysis of the Germinal Center Reaction in Tissue Sections
Dominguez-Sola, D., & Cattoretti, G. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7095-7_1 · Cited by 3
Self-citationIsmail, S., Elshimali, Y., Daoud, A. K., & Alshehabi, Z. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103786 · Cited by 3
Role of Biomarkers in Personalized Medicine
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-5759-7_10 · Cited by 4
Metadata
- Authors
- Cattoretti, G., Pasqualucci, L., Ballon, G., Tam, W., Nandula, S. V., Shen, Q., Mo, T., Murty, V. V., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 7
- Issue
- 5
- Pages
- 445-455
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2091213817
- Cited by
- 383
- References
- 48
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 15 · 2023: 24 · 2022: 15 · 2021: 23 · 2020: 19 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 22 · 2015: 17 · 2014: 15 · 2013: 17 · 2012: 23
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Columbia Academic Commons (Columbia University)
- Funders
- National Cancer Institute (P01CA092625, CA092625)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- BCL6, diffuse large B-cell lymphoma, germinal center, chromosomal translocation, class switch recombination, plasma cells, lymphoproliferative disorders, B-cell lymphomagenesis
- MeSH terms
- Animals, Cell Differentiation, Chromosome Aberrations, Disease Models, Animal, DNA-Binding Proteins, Genes, Immunoglobulin, Hemagglutinins, Humans, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Plasma Cells, Promoter Regions, Genetic, Spleen, Splenomegaly, Time Factors, Gene Expression, Survival Analysis, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Mice, Knockout, Germinal Center, Mice, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review